selpercatinib

A groundbreaking cancer drug nabs fast OK, giving Eli Lilly boasting rights as a rival speeds close behind
Endpoints
Sun, 05/10/20 - 09:30 pm
Eli Lilly
selpercatinib
Retevmo
FDA
cancer
Loxo Oncology
Blueprint Medicines
FDA Speeds Up Examination of 5 Drugs with Priority Review
BioSpace
Thu, 02/13/20 - 12:24 am
FDA
priority review
capmatinib
Kite Pharma
KTE-X19
Eli Lilly
selpercatinib
GSK
belantamab mafodotin
Astex
C-DEC
Racing Blueprint, Lilly drug gets priority review for RET hopeful
Fierce Biotech
Wed, 01/29/20 - 10:35 am
Eli Lilly
FDA
Blueprint Medicines
selpercatinib
LOXO-292
thyroid cancer
non-small cell lung cancer